BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 18930040)

  • 1. Low basal levels of circulating adiponectin in patients undergoing coronary stenting predict in-stent restenosis, independently of basal levels of inflammatory markers: lipoprotein associated phospholipase A2, and myeloperoxidase.
    Moldoveanu E; Mut-Vitcu B; Tanaseanu GR; Marta DS; Manea G; Kosaka T; Vidulescu C; Tanaseanu C
    Clin Biochem; 2008 Dec; 41(18):1429-33. PubMed ID: 18930040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous coronary intervention triggers a systemic inflammatory response in patients treated for in-stent restenosis -- comparison with stable and unstable angina.
    Kozinski M; Krzewina-Kowalska A; Kubica J; Zbikowska-Gotz M; Dymek G; Piasecki R; Sukiennik A; Grzesk G; Bogdan M; Chojnicki M; Dziedziczko A; Sypniewska G
    Inflamm Res; 2005 May; 54(5):187-93. PubMed ID: 15953990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low adiponectin levels predict late in-stent restenosis after bare metal stenting in native coronary arteries.
    Kitta Y; Takano H; Nakamura T; Kodama Y; Umetani K; Fujioka D; Saito Y; Kawabata K; Obata JE; Mende A; Kobayashi T; Kugiyama K
    Int J Cardiol; 2008 Dec; 131(1):78-82. PubMed ID: 18180052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the circulating adiponectin concentration with coronary in-stent restenosis in haemodialysis patients.
    Nishimura M; Hashimoto T; Kobayashi H; Yamazaki S; Okino K; Fujita H; Inoue N; Takahashi H; Ono T
    Nephrol Dial Transplant; 2006 Jun; 21(6):1640-7. PubMed ID: 16431887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial vasomotor dysfunction in the brachial artery is associated with late in-stent coronary restenosis.
    Kitta Y; Nakamura T; Kodama Y; Takano H; Umetani K; Fujioka D; Saito Y; Kawabata K; Obata JE; Ichigi Y; Mende A; Kugiyama K
    J Am Coll Cardiol; 2005 Aug; 46(4):648-55. PubMed ID: 16098430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum concentration of insulin-like growth factor-I, but not tumor necrosis factor-alpha, measured twelve months after stenting of the infarct-related artery, is associated with in-stent restenosis.
    Szkodzinski J; Hudzik B; Romanowski W; Wilczek K; Danikiewicz A; Gasior M; Polonski L; Zubelewicz-Szkodzinska B
    J Biol Regul Homeost Agents; 2010; 24(2):149-56. PubMed ID: 20487628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Potential of plasma adiponectin concentrations as a predictive marker for in-stent restenosis after percutaneous coronary intervention in patients on hemodialysis].
    Nishimura M; Takahashi H
    Rinsho Byori; 2011 Aug; 59(8):795-800. PubMed ID: 21942090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association between plasma adiponectin level and in-stent restenosis after coronary stenting].
    Qin Q; Lu YR; Li Y; Kou L; Feng JP; Chen G; Li CJ; Zhao BR
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Mar; 38(3):239-42. PubMed ID: 20450566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between preheparin lipoprotein lipase mass concentration in serum and bare metal stent restenosis.
    Hitsumoto T; Takahashi M; Iizuka T; Shirai K
    J Cardiol; 2006 Aug; 48(2):65-73. PubMed ID: 16948449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis.
    Gao J; Liu Y; Cui RZ; Mao YM; Zhou J; Chen Q; Zhao FM; Yang GM
    Chin Med J (Engl); 2013 Mar; 126(6):1019-25. PubMed ID: 23506572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different impacts of C-reactive protein and lipid profile on coronary lesions following a percutaneous coronary intervention.
    Xu HY; Qiao SB; Zhang JF; Dong QT; Li JJ
    Coron Artery Dis; 2012 May; 23(3):181-7. PubMed ID: 22336660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of lipoprotein-associated phospholipase A2 for prediction of 30-day major adverse coronary event in patients with the first anterior ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Stankovic S; Asanin M; Trifunovic D; Majkic-Singh N; Miljković A; Ignjatovic S; Mrdovic I; Matic D; Savic L; Ostojic M; Vasiljevic Z
    Clin Lab; 2012; 58(11-12):1135-44. PubMed ID: 23289182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High soluble Fas and soluble Fas Ligand serum levels before stent implantation are protective against restenosis.
    Katsaros KM; Wiesbauer F; Speidl WS; Kastl SP; Huber K; Zorn G; Niessner A; Glogar D; Maurer G; Wojta J
    Thromb Haemost; 2011 May; 105(5):883-91. PubMed ID: 21359408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of in-stent restenosis and patient outcome after percutaneous coronary intervention in patients with diabetes mellitus.
    Sukhija R; Aronow WS; Sureddi R; Aleti S; Molavi B; Sachdeva R; Mehta JL
    Am J Cardiol; 2007 Sep; 100(5):777-80. PubMed ID: 17719319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periprocedural soluble P- and E-selectin levels fail as predictors of clinical restenosis in patients treated with elective coronary stenting.
    Kozinski M; Kubica J; Sukiennik A; Zbikowska-Gotz M; Krzewina-Kowalska A; Radomski M; Rychter M; Bialoszynski T; Jablonski M; Demidowicz K; Grzesk G; Bogdan M; Chojnicki M; Grabczewska S; Dziedziczko A
    Int J Mol Med; 2007 Jan; 19(1):187-95. PubMed ID: 17143564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent high levels of plasma oxidized low-density lipoprotein after acute myocardial infarction predict stent restenosis.
    Naruko T; Ueda M; Ehara S; Itoh A; Haze K; Shirai N; Ikura Y; Ohsawa M; Itabe H; Kobayashi Y; Yamagishi H; Yoshiyama M; Yoshikawa J; Becker AE
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):877-83. PubMed ID: 16469945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is inflammation a contributor for coronary stent restenosis?
    Li JJ; Nie SP; Zhang CY; Gao Z; Zheng X; Guo YL
    Med Hypotheses; 2007; 68(5):945-51. PubMed ID: 17045418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of MMP-3, MMP-9 and MPO represent predictors of in-stent restenosis, while increased levels of ADMA, LCAT, ApoE and ApoD predict bare metal stent patency.
    Pleva L; Kusnierova P; Plevova P; Zapletalova J; Karpisek M; Faldynova L; Kovarova P; Kukla P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Dec; 159(4):586-94. PubMed ID: 26365933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased ratio of high-molecular-weight to total adiponectin is associated with angiographic coronary atherosclerosis severity but not restenosis.
    Liang KW; Lee WJ; Lee WL; Ting CT; Sheu WH
    Clin Chim Acta; 2009 Jul; 405(1-2):114-8. PubMed ID: 19397903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease.
    Türker S; Güneri S; Akdeniz B; Ozcan MA; Baris N; Badak O; Kirimli O; Yüksel F
    Am J Cardiol; 2006 Jan; 97(2):198-202. PubMed ID: 16442363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.